JNJ-54452840

JNJ-54452840 Uses, Dosage, Side Effects, Food Interaction and all others data.

JNJ-54452840 is under investigation in clinical trial NCT01798745 (A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies).

Trade Name JNJ-54452840
Generic Mibenratide
Mibenratide Other Names JNJ-54452840, Mibenratide
Type
Formula C87H129N27O30S2
Weight Average: 2097.27
Monoisotopic: 2095.88400821
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
JNJ-54452840
JNJ-54452840

Innovators Monograph

You find simplified version here JNJ-54452840


*** Taking medicines without doctor's advice can cause long-term problems.
Share